- Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics? Yahoo Finance
- Roche Climbs As Once-Daily Weight Loss Pill Shows Promise Forbes
- Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche CNBC
- Roche’s $2.7B weight-loss wager delivers early oral GLP-1 win Fierce Biotech
- Roche obesity-pill trial results weigh on shares of Eli Lilly, Novo Nordisk MarketWatch
Wednesday, July 17, 2024
Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics? - Yahoo Finance
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment